Literature DB >> 8228927

Detection of IgA class antibody to hepatitis E virus in serum samples from patients with hepatitis E virus infection.

K H Chau1, G J Dawson, K M Bile, L O Magnius, M H Sjogren, I K Mushahwar.   

Abstract

A newly developed assay for IgA class antibody to hepatitis E virus (IgA anti-HEV) was used to study 145 serum samples collected during an outbreak of an enterically transmitted hepatitis that occurred in 3 villages in the lower Shebeli region of Southern Somalia between January, 1988 and November, 1989. A total of 52.4% of the afflicted patients were found positive for IgA anti-HEV, and 73.1% of these were also positive for IgM. Both antibodies disappeared during the convalescence period. Similar results were also seen in serum obtained from sporadic cases of acute waterborne hepatitis in Pakistan.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8228927     DOI： 10.1002/jmv.1890400414

Source DB:  PubMed          Journal:  J Med Virol        ISSN： 0146-6615            Impact factor:   2.327


  11 in total

1.  Acute hepatitis E in Catania (eastern Sicily) 1980-1994. The role of hepatitis E virus.

Authors:  B Cacopardo; R Russo; W Preiser; F Benanti; G Brancati; A Nunnari
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 3.553

Review 2.  Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-09-03       Impact factor: 6.915

3.  Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4.

Authors:  Y Wang; H Zhang; Z Li; W Gu; H Lan; W Hao; R Ling; H Li; T J Harrison
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

4.  Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection.

Authors:  Masaharu Takahashi; Shigeyuki Kusakai; Hitoshi Mizuo; Kazuyuki Suzuki; Kuniko Fujimura; Kazuo Masuko; Yoshiki Sugai; Tatsuya Aikawa; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

5.  Detection of hepatitis E virus-specific immunoglobulin a in patients infected with hepatitis E virus genotype 1 or 3.

Authors:  M Herremans; E Duizer; E Jusic; M P G Koopmans
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

6.  Consecutive evaluation of immunoglobulin M and G antibodies against hepatitis E virus.

Authors:  W M Ke; D Tan; J G Li; S Izumi; Y Shinji; H Hotta; J L Yao
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

7.  Hepatitis E antibody profiles in serum and urine.

Authors:  M S Joshi; A M Walimbe; V A Arankalle; M S Chadha; S D Chitambar
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

8.  Clinical significance of anti-HEV IgA in diagnosis of acute genotype 4 hepatitis E virus infection negative for anti-HEV IgM.

Authors:  Shujun Zhang; Deying Tian; Zhengang Zhang; Junhui Xiong; Quan Yuan; Shengxiang Ge; Jun Zhang; Ningshao Xia
Journal:  Dig Dis Sci       Date:  2009-01-01       Impact factor: 3.199

9.  Artificial mosaic protein containing antigenic epitopes of hepatitis E virus.

Authors:  Y E Khudyakov; M O Favorov; N S Khudyakova; M E Cong; B P Holloway; N Padhye; S B Lambert; D L Jue; H A Fields
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

10.  Hepatitis E virus prevalence among blood donors in Dali, China.

Authors:  Ping Fu; Baochai Lin; Bingting Wu; Ling Ke; Tianfu Yang; Yue'e Du; Lishan Cheng; Zhou Li; Tiancheng Li; Yu Liu
Journal:  Virol J       Date:  2021-07-07       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.